Protagonist Therapeutics, Inc — Director's Dealing 2018

Mar 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2018-02-28

Reporting Person: Liu David Y (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-28	Common Stock	A	9500	$0.00	Acquired	13322	Direct
2018-03-02	Common Stock	M	875	$1.89	Acquired	14197	Direct
2018-03-02	Common Stock	S	875	$20.00	Disposed	13322	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-28	Employee Stock Option (right to buy)	$16.95	A	56500	Acquired	2028-02-27	Common Stock (56500)	Direct
2018-03-02	Employee Stock Option (right to buy)	$1.89	M	875	Disposed	2024-10-22	Common Stock (875)	Direct

Footnotes

F1: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2017.

F3: The shares underlying this option shall vest as to 25% after one year following the grant date, and the remainder will vest in equal monthly installments over the following three years.

F4: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.